|
Protein Sciences Corporation is a vaccine company focused primarily on using modern technology to make the next generation of safer and more effective human and animal vaccines for influenza, SARS and other diseases. We develop all of our products internally and own commercialization rights to these products. Our service businesses manufacture pharmaceutical and research proteins and products for customers.
 Our GENEXPRESS® service business is used to develop and manufacture pharmaceutical and research proteins for customers.
|
|
|
 |
 |
Results from 2004-2005 FluBlØk™ field study prompts the FDA to advise us that FluBlØk™ could qualify for the "accelerated" approval mechanism. As a result, the pivotal clinical end point study can be conducted post market approval.
|
 |
 |
Our products include complex proteins for research use, our patented serum-free expresSF+® cells, and the GeneXpress BaculoKIT™, our baculovirus protein expression kit.
|
|
|
